NO317293B1 - Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse - Google Patents
Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse Download PDFInfo
- Publication number
- NO317293B1 NO317293B1 NO20003285A NO20003285A NO317293B1 NO 317293 B1 NO317293 B1 NO 317293B1 NO 20003285 A NO20003285 A NO 20003285A NO 20003285 A NO20003285 A NO 20003285A NO 317293 B1 NO317293 B1 NO 317293B1
- Authority
- NO
- Norway
- Prior art keywords
- mmol
- tetrahydro
- compound
- synthesis example
- group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 413
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- GHDKZRYOSSRTLA-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-benzo[g]indole Chemical class C1C=C2C=CC=CC2=C2C1CCN2 GHDKZRYOSSRTLA-UHFFFAOYSA-N 0.000 title description 7
- 239000012450 pharmaceutical intermediate Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 38
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims abstract description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims description 39
- -1 t-butoxycarbonyl Chemical group 0.000 claims description 34
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 24
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 14
- 125000005843 halogen group Chemical group 0.000 claims description 10
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 8
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 208000020016 psychiatric disease Diseases 0.000 claims description 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 4
- 229910052727 yttrium Inorganic materials 0.000 claims description 4
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims description 3
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 abstract description 15
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract description 14
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract description 5
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract description 5
- 230000005856 abnormality Effects 0.000 abstract description 5
- 229940076279 serotonin Drugs 0.000 abstract description 5
- 229910052717 sulfur Inorganic materials 0.000 abstract description 4
- 230000002093 peripheral effect Effects 0.000 abstract description 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 description 752
- 238000003786 synthesis reaction Methods 0.000 description 284
- 230000015572 biosynthetic process Effects 0.000 description 283
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 261
- 239000000243 solution Substances 0.000 description 222
- 238000001819 mass spectrum Methods 0.000 description 173
- 238000006243 chemical reaction Methods 0.000 description 146
- 239000002904 solvent Substances 0.000 description 132
- 230000002829 reductive effect Effects 0.000 description 131
- 238000005160 1H NMR spectroscopy Methods 0.000 description 125
- 238000001704 evaporation Methods 0.000 description 121
- 230000008020 evaporation Effects 0.000 description 110
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 107
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 103
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 101
- 238000000034 method Methods 0.000 description 100
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 91
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 85
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 81
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 78
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 66
- 238000010898 silica gel chromatography Methods 0.000 description 62
- 239000000463 material Substances 0.000 description 61
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 52
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 44
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 42
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 42
- 101150041968 CDC13 gene Proteins 0.000 description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 40
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 40
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 40
- 238000005481 NMR spectroscopy Methods 0.000 description 38
- WTHVGNDEIMLIHE-UHFFFAOYSA-N n-methyl-2-[2-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-3,4-dihydro-1h-pyrido[3,4-b]indol-9-yl]acetamide Chemical compound C12=CC=CC=C2N(CC(=O)NC)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 WTHVGNDEIMLIHE-UHFFFAOYSA-N 0.000 description 32
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 31
- 239000012044 organic layer Substances 0.000 description 31
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 30
- 239000007795 chemical reaction product Substances 0.000 description 30
- 239000000203 mixture Substances 0.000 description 26
- 229910000027 potassium carbonate Inorganic materials 0.000 description 26
- 235000011181 potassium carbonates Nutrition 0.000 description 26
- 239000011734 sodium Substances 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- 239000011541 reaction mixture Substances 0.000 description 23
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 22
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 22
- 239000012312 sodium hydride Substances 0.000 description 22
- 229910000104 sodium hydride Inorganic materials 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 238000010828 elution Methods 0.000 description 21
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 20
- 239000000460 chlorine Substances 0.000 description 20
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 19
- 238000001914 filtration Methods 0.000 description 18
- 239000002585 base Substances 0.000 description 17
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 16
- XVCXKZISCOBPDZ-UHFFFAOYSA-N 2a-(4-bromobutyl)-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC3=C2C1(CCCCBr)C(=O)N3 XVCXKZISCOBPDZ-UHFFFAOYSA-N 0.000 description 14
- 239000002253 acid Substances 0.000 description 14
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 14
- 239000013078 crystal Substances 0.000 description 14
- 238000001035 drying Methods 0.000 description 14
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 14
- 239000013067 intermediate product Substances 0.000 description 14
- GFJCZDJPSXKGSF-UHFFFAOYSA-N tert-butyl 1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate Chemical compound N1C2=CC=CC=C2C2=C1CN(C(=O)OC(C)(C)C)CC2 GFJCZDJPSXKGSF-UHFFFAOYSA-N 0.000 description 14
- OGUWOLDNYOTRBO-UHFFFAOYSA-N 4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1NCCC2=C1C=CS2 OGUWOLDNYOTRBO-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 12
- 108091005436 5-HT7 receptors Proteins 0.000 description 11
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 11
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 125000006239 protecting group Chemical group 0.000 description 11
- HUCMZMNAPUWYOC-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-1-yl)piperazine;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C1N1CCNCC1 HUCMZMNAPUWYOC-UHFFFAOYSA-N 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- CFTOTSJVQRFXOF-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole Chemical class N1C2=CC=CC=C2C2=C1CNCC2 CFTOTSJVQRFXOF-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 8
- YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical compound C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 8
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- GDQBPBMIAFIRIU-UHFFFAOYSA-N thieno[2,3-c]pyridine Chemical compound C1=NC=C2SC=CC2=C1 GDQBPBMIAFIRIU-UHFFFAOYSA-N 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 239000012298 atmosphere Substances 0.000 description 7
- 230000027455 binding Effects 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- GOUUEYJGXNNEIV-UHFFFAOYSA-N tert-butyl 4-(6,7,8,9-tetrahydro-5h-benzo[7]annulen-5-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1C2=CC=CC=C2CCCC1 GOUUEYJGXNNEIV-UHFFFAOYSA-N 0.000 description 7
- UWYZHKAOTLEWKK-UHFFFAOYSA-N tetrahydro-isoquinoline Natural products C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 6
- 239000012442 inert solvent Substances 0.000 description 6
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000012266 salt solution Substances 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- DOBGHCDMPAGIGS-UHFFFAOYSA-N tert-butyl 4-(2,3-dihydro-1h-inden-1-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1C2=CC=CC=C2CC1 DOBGHCDMPAGIGS-UHFFFAOYSA-N 0.000 description 6
- ZXLDQJLIBNPEFJ-UHFFFAOYSA-N tetrahydro-beta-carboline Natural products C1CNC(C)C2=C1C1=CC=C(OC)C=C1N2 ZXLDQJLIBNPEFJ-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- PTLTZFJYSSVFEC-UHFFFAOYSA-N 2-methyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1NCCC2=C1C=C(C)S2 PTLTZFJYSSVFEC-UHFFFAOYSA-N 0.000 description 5
- VYACEHZLOWZZEV-UHFFFAOYSA-N 5-[(2-methylpropan-2-yl)oxycarbonyl]-6,7-dihydro-4h-thieno[3,2-c]pyridine-2-carboxylic acid Chemical compound C1N(C(=O)OC(C)(C)C)CCC2=C1C=C(C(O)=O)S2 VYACEHZLOWZZEV-UHFFFAOYSA-N 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 5
- 239000007868 Raney catalyst Substances 0.000 description 5
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- 229910000564 Raney nickel Inorganic materials 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 5
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 5
- 229910003446 platinum oxide Inorganic materials 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- XCZJAIPXDKUJPJ-UHFFFAOYSA-N 2-o-tert-butyl 9-o-methyl 3,4-dihydro-1h-pyrido[3,4-b]indole-2,9-dicarboxylate Chemical compound C12=CC=CC=C2N(C(=O)OC)C2=C1CCN(C(=O)OC(C)(C)C)C2 XCZJAIPXDKUJPJ-UHFFFAOYSA-N 0.000 description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 4
- ZUZMVTSAPQEJGT-UHFFFAOYSA-N 3-methyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1CNCC2=C1SC=C2C ZUZMVTSAPQEJGT-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 150000002148 esters Chemical group 0.000 description 4
- 238000005658 halogenation reaction Methods 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- AAZYNPCMLRQUHI-UHFFFAOYSA-N propan-2-one;2-propan-2-yloxypropane Chemical compound CC(C)=O.CC(C)OC(C)C AAZYNPCMLRQUHI-UHFFFAOYSA-N 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 3
- SQEZXFSADTVEQB-UHFFFAOYSA-N 1-methylbenzo[cd]indol-2-one Chemical compound C1=CC(N(C)C2=O)=C3C2=CC=CC3=C1 SQEZXFSADTVEQB-UHFFFAOYSA-N 0.000 description 3
- FGGBJUOJAKQFRD-UHFFFAOYSA-N 1-oxido-5,6,7,8-tetrahydroquinolin-1-ium Chemical compound C1CCCC2=C1C=CC=[N+]2[O-] FGGBJUOJAKQFRD-UHFFFAOYSA-N 0.000 description 3
- MIBUNYFPYOXIFZ-UHFFFAOYSA-N 2,3-dimethyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1CNCC2=C1SC(C)=C2C MIBUNYFPYOXIFZ-UHFFFAOYSA-N 0.000 description 3
- CRJMOQUKRGIGLY-UHFFFAOYSA-N 2a,3,4,5-tetrahydro-1h-benzo[cd]indol-2-one Chemical compound C1CCC2C(=O)NC3=CC=CC1=C32 CRJMOQUKRGIGLY-UHFFFAOYSA-N 0.000 description 3
- QHZLYKACDALOBB-UHFFFAOYSA-N 2a-(3-bromopropyl)-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC3=C2C1(CCCBr)C(=O)N3 QHZLYKACDALOBB-UHFFFAOYSA-N 0.000 description 3
- MGSHXMOLUWTMGP-UHFFFAOYSA-N 3'-carboxy-alpha-chromanol Chemical compound C1=CC=C2C(O)CCOC2=C1 MGSHXMOLUWTMGP-UHFFFAOYSA-N 0.000 description 3
- CNXFGNVBRLEVBD-UHFFFAOYSA-N 4,5,6,7-tetrahydrofuro[3,2-c]pyridine Chemical compound C1NCCC2=C1C=CO2 CNXFGNVBRLEVBD-UHFFFAOYSA-N 0.000 description 3
- BSDGZUDFPKIYQG-UHFFFAOYSA-N 4-bromopyridine Chemical compound BrC1=CC=NC=C1 BSDGZUDFPKIYQG-UHFFFAOYSA-N 0.000 description 3
- YCQHYOBSOVFBEB-UHFFFAOYSA-N 5,6,7,8-tetrahydroquinolin-8-ol Chemical compound C1=CN=C2C(O)CCCC2=C1 YCQHYOBSOVFBEB-UHFFFAOYSA-N 0.000 description 3
- QTEIQTRPDDPVKV-UHFFFAOYSA-N 5,6,7,8-tetrahydroquinolin-8-yl acetate Chemical compound C1=CN=C2C(OC(=O)C)CCCC2=C1 QTEIQTRPDDPVKV-UHFFFAOYSA-N 0.000 description 3
- HZPXWGZCCZHHFH-UHFFFAOYSA-N 9-bromo-6,7,8,9-tetrahydrobenzo[7]annulen-5-one Chemical compound BrC1CCCC(=O)C2=CC=CC=C12 HZPXWGZCCZHHFH-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000005909 Kieselgur Substances 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 3
- 239000012346 acetyl chloride Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000010933 acylation Effects 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000010531 catalytic reduction reaction Methods 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000026030 halogenation Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- OFCCYDUUBNUJIB-UHFFFAOYSA-N n,n-diethylcarbamoyl chloride Chemical compound CCN(CC)C(Cl)=O OFCCYDUUBNUJIB-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
- 239000011736 potassium bicarbonate Substances 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 150000003335 secondary amines Chemical class 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- DUXYNAUJNWHWLS-UHFFFAOYSA-N tert-butyl 2,4,4a,5-tetrahydro-1h-pyrazino[2,1-c][1,4]benzothiazine-3-carboxylate Chemical compound C1=CC=C2N3CCN(C(=O)OC(C)(C)C)CC3CSC2=C1 DUXYNAUJNWHWLS-UHFFFAOYSA-N 0.000 description 3
- WNASTMXQUJOXDJ-UHFFFAOYSA-N tert-butyl 2-carbamoyl-6,7-dihydro-4h-thieno[3,2-c]pyridine-5-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC2=C1C=C(C(N)=O)S2 WNASTMXQUJOXDJ-UHFFFAOYSA-N 0.000 description 3
- QDJSWSBQYDDJGI-UHFFFAOYSA-N tert-butyl 3-methyl-6,7-dihydro-4h-thieno[3,2-c]pyridine-5-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CC2=C1SC=C2C QDJSWSBQYDDJGI-UHFFFAOYSA-N 0.000 description 3
- DGYXRUYCQAYVDM-UHFFFAOYSA-N tert-butyl 6,7-dihydro-4h-thieno[3,2-c]pyridine-5-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC2=C1C=CS2 DGYXRUYCQAYVDM-UHFFFAOYSA-N 0.000 description 3
- OJCPAWSZNLDKDV-UHFFFAOYSA-N tert-butyl 9-(2-methoxy-2-oxoethyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(CC(=O)OC)C2=C1CCN(C(=O)OC(C)(C)C)C2 OJCPAWSZNLDKDV-UHFFFAOYSA-N 0.000 description 3
- XKXIQBVKMABYQJ-UHFFFAOYSA-N tert-butyl hydrogen carbonate Chemical compound CC(C)(C)OC(O)=O XKXIQBVKMABYQJ-UHFFFAOYSA-N 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical class SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical class C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- LDUZILRBWUAJLE-UHFFFAOYSA-N 1,2,3,4-tetrahydro-[1]benzofuro[2,3-c]pyridine Chemical compound O1C2=CC=CC=C2C2=C1CNCC2 LDUZILRBWUAJLE-UHFFFAOYSA-N 0.000 description 2
- LOSHLRVJQKCQNH-UHFFFAOYSA-N 1,2,3,4-tetrahydro-[1]benzothiolo[2,3-c]pyridine Chemical compound S1C2=CC=CC=C2C2=C1CNCC2 LOSHLRVJQKCQNH-UHFFFAOYSA-N 0.000 description 2
- XDHYTSMMYGWXFI-UHFFFAOYSA-N 1,2,3,4-tetrahydro-[1]benzothiolo[2,3-c]pyridine;hydrochloride Chemical compound Cl.S1C2=CC=CC=C2C2=C1CNCC2 XDHYTSMMYGWXFI-UHFFFAOYSA-N 0.000 description 2
- FHTDAVICELDDEP-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrido[3,4-b]indole-9-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(C(=O)N)C2=C1CCNC2 FHTDAVICELDDEP-UHFFFAOYSA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 2
- KBNFLEIETBDDCM-UHFFFAOYSA-N 1-(1,2,3,4,4a,5-hexahydropyrazino[1,2-a]quinoxalin-6-yl)-2,2,2-trifluoroethanone;hydrochloride Chemical compound Cl.C12=CC=CC=C2N(C(=O)C(F)(F)F)CC2N1CCNC2 KBNFLEIETBDDCM-UHFFFAOYSA-N 0.000 description 2
- PCWDIVRWNCOMOW-UHFFFAOYSA-N 1-(1,2,3,4-tetrahydronaphthalen-1-yl)piperidine;hydrochloride Chemical compound Cl.C1CCCCN1C1C2=CC=CC=C2CCC1 PCWDIVRWNCOMOW-UHFFFAOYSA-N 0.000 description 2
- VZSWVECFWCGGRD-UHFFFAOYSA-N 1-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)propan-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(CC(=O)C)C2=C1CCNC2 VZSWVECFWCGGRD-UHFFFAOYSA-N 0.000 description 2
- MMUMHCHGKODAIZ-UHFFFAOYSA-N 1-(2-phenylpropan-2-yl)piperazine Chemical compound C=1C=CC=CC=1C(C)(C)N1CCNCC1 MMUMHCHGKODAIZ-UHFFFAOYSA-N 0.000 description 2
- PTKBLKMIBNIWKW-UHFFFAOYSA-N 1-(3,4-dihydro-2h-chromen-4-yl)piperazine;hydrochloride Chemical compound Cl.C1CNCCN1C1C2=CC=CC=C2OCC1 PTKBLKMIBNIWKW-UHFFFAOYSA-N 0.000 description 2
- YEZOMSWXFZSYFB-UHFFFAOYSA-N 1-(3,4-dihydro-2h-thiochromen-4-yl)piperazine;hydrochloride Chemical compound Cl.C1CNCCN1C1C2=CC=CC=C2SCC1 YEZOMSWXFZSYFB-UHFFFAOYSA-N 0.000 description 2
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 2
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical compound C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 description 2
- BYZKRKXJSNSHEE-UHFFFAOYSA-N 1-ethyl-2-benzo[cd]indolone Chemical compound C1=CC(N(CC)C2=O)=C3C2=CC=CC3=C1 BYZKRKXJSNSHEE-UHFFFAOYSA-N 0.000 description 2
- KXPKPBDFRGOZMB-UHFFFAOYSA-N 1-ethyl-2a,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC3=C2C1C(=O)N3CC KXPKPBDFRGOZMB-UHFFFAOYSA-N 0.000 description 2
- OHMYJENBKYRFGD-UHFFFAOYSA-N 1-pyridin-4-yl-2,3-dihydroinden-1-ol Chemical compound C1CC2=CC=CC=C2C1(O)C1=CC=NC=C1 OHMYJENBKYRFGD-UHFFFAOYSA-N 0.000 description 2
- ZCYWNEIJWZMTDS-UHFFFAOYSA-N 1-pyridin-4-yl-3,4-dihydro-2h-naphthalen-1-ol Chemical compound C1CCC2=CC=CC=C2C1(O)C1=CC=NC=C1 ZCYWNEIJWZMTDS-UHFFFAOYSA-N 0.000 description 2
- GPYLCFQEKPUWLD-UHFFFAOYSA-N 1h-benzo[cd]indol-2-one Chemical compound C1=CC(C(=O)N2)=C3C2=CC=CC3=C1 GPYLCFQEKPUWLD-UHFFFAOYSA-N 0.000 description 2
- PVOSECZBLPUJLZ-UHFFFAOYSA-N 2,3,4,4a,5,6-hexahydro-1h-pyrazino[1,2-a]quinoxaline Chemical class C1=CC=C2N3CCNCC3CNC2=C1 PVOSECZBLPUJLZ-UHFFFAOYSA-N 0.000 description 2
- WWQPGNZHJFFKRW-UHFFFAOYSA-N 2,3,4,5-tetrahydro-2-benzazepin-1-one Chemical compound O=C1NCCCC2=CC=CC=C12 WWQPGNZHJFFKRW-UHFFFAOYSA-N 0.000 description 2
- CBKHEZWKYMWCKX-UHFFFAOYSA-N 2-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)acetonitrile;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(CC#N)C2=C1CCNC2 CBKHEZWKYMWCKX-UHFFFAOYSA-N 0.000 description 2
- UAFBGDLXUIBTFM-UHFFFAOYSA-N 2-(1-benzylpiperidin-4-yl)-3,4-dihydro-1h-isoquinoline Chemical compound C1CC(N2CC3=CC=CC=C3CC2)CCN1CC1=CC=CC=C1 UAFBGDLXUIBTFM-UHFFFAOYSA-N 0.000 description 2
- UPVSBCHZSIHTBX-UHFFFAOYSA-N 2-(4-benzylpiperazin-1-yl)-2-methylpropanenitrile Chemical compound C1CN(C(C)(C#N)C)CCN1CC1=CC=CC=C1 UPVSBCHZSIHTBX-UHFFFAOYSA-N 0.000 description 2
- NMIOWXDCRJVKAY-UHFFFAOYSA-N 2-[2-[(2-methylpropan-2-yl)oxycarbonyl]-3,4-dihydro-1h-pyrido[3,4-b]indol-9-yl]acetic acid Chemical compound OC(=O)CN1C2=CC=CC=C2C2=C1CN(C(=O)OC(C)(C)C)CC2 NMIOWXDCRJVKAY-UHFFFAOYSA-N 0.000 description 2
- MYWFDOPJSJFFBX-UHFFFAOYSA-N 2-[benzyl(furan-3-ylmethyl)amino]ethanol Chemical compound C=1C=CC=CC=1CN(CCO)CC=1C=COC=1 MYWFDOPJSJFFBX-UHFFFAOYSA-N 0.000 description 2
- JUIKUQOUMZUFQT-UHFFFAOYSA-N 2-bromoacetamide Chemical compound NC(=O)CBr JUIKUQOUMZUFQT-UHFFFAOYSA-N 0.000 description 2
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 2
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 2
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 2
- AQEYJNQCMXIBFF-UHFFFAOYSA-N 2-oxido-5,6,7,8-tetrahydroisoquinolin-2-ium Chemical compound C1CCCC2=C[N+]([O-])=CC=C21 AQEYJNQCMXIBFF-UHFFFAOYSA-N 0.000 description 2
- VIDWEXGVLRTXHK-UHFFFAOYSA-N 2-piperidin-4-yl-3,4-dihydro-1h-isoquinoline;dihydrobromide Chemical compound Br.Br.C1CNCCC1N1CC2=CC=CC=C2CC1 VIDWEXGVLRTXHK-UHFFFAOYSA-N 0.000 description 2
- OJYTXMKMQSNBNA-UHFFFAOYSA-N 2a-(4-bromobutyl)-1-ethyl-4,5-dihydro-3h-benzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC3=C2C1(CCCCBr)C(=O)N3CC OJYTXMKMQSNBNA-UHFFFAOYSA-N 0.000 description 2
- LESDSISTSSTPBO-UHFFFAOYSA-N 2a-[4-(1,2,4,4a,5,6-hexahydropyrazino[1,2-a]quinoxalin-3-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1C2CNC3=CC=CC=C3N2CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 LESDSISTSSTPBO-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- ZPIFAYFILYYZIG-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridine;dihydrochloride Chemical compound Cl.Cl.C1NCCC2=C1C=NN2 ZPIFAYFILYYZIG-UHFFFAOYSA-N 0.000 description 2
- YUHGQAJWDAKLGV-UHFFFAOYSA-N 4,5,6,7-tetrahydro-3h-imidazo[4,5-c]pyridine;hydrate;dihydrochloride Chemical compound O.Cl.Cl.C1NCCC2=C1NC=N2 YUHGQAJWDAKLGV-UHFFFAOYSA-N 0.000 description 2
- ZKAYEFAKZWTAGS-UHFFFAOYSA-N 4,5,6,7-tetrahydrofuro[2,3-c]pyridine Chemical compound C1NCCC2=C1OC=C2 ZKAYEFAKZWTAGS-UHFFFAOYSA-N 0.000 description 2
- HXNOEHIMWZDRTK-UHFFFAOYSA-N 4,5,6,7-tetrahydrothieno[2,3-c]pyridine Chemical compound C1NCCC2=C1SC=C2 HXNOEHIMWZDRTK-UHFFFAOYSA-N 0.000 description 2
- ANKLNNCOMMHGOL-UHFFFAOYSA-N 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxamide Chemical compound C1NCCC2=C1C=C(C(=O)N)S2 ANKLNNCOMMHGOL-UHFFFAOYSA-N 0.000 description 2
- MEYKBMVFEXLJDF-UHFFFAOYSA-N 4-(2,3-dihydro-1h-inden-1-yl)piperidine;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C1C1CCNCC1 MEYKBMVFEXLJDF-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- FZUMQCKAVKSWLQ-UHFFFAOYSA-N 5,6,7,8-tetrahydroisoquinolin-5-ol Chemical compound N1=CC=C2C(O)CCCC2=C1 FZUMQCKAVKSWLQ-UHFFFAOYSA-N 0.000 description 2
- WBIXPHWUULORGW-UHFFFAOYSA-N 5,6,7,8-tetrahydroisoquinolin-5-yl acetate Chemical compound N1=CC=C2C(OC(=O)C)CCCC2=C1 WBIXPHWUULORGW-UHFFFAOYSA-N 0.000 description 2
- YQDGQEKUTLYWJU-UHFFFAOYSA-N 5,6,7,8-tetrahydroquinoline Chemical compound C1=CC=C2CCCCC2=N1 YQDGQEKUTLYWJU-UHFFFAOYSA-N 0.000 description 2
- MRHRDZQVWVKPIJ-UHFFFAOYSA-N 5-benzyl-6,7-dihydro-4h-furo[3,2-c]pyridine Chemical compound C1CC=2OC=CC=2CN1CC1=CC=CC=C1 MRHRDZQVWVKPIJ-UHFFFAOYSA-N 0.000 description 2
- HPLVZHZIUJGIDQ-UHFFFAOYSA-N 5-fluoro-1,2,3,4-tetrahydroisoquinoline Chemical compound C1NCCC2=C1C=CC=C2F HPLVZHZIUJGIDQ-UHFFFAOYSA-N 0.000 description 2
- ZZGXLZYBHQFPQV-UHFFFAOYSA-N 5-fluoro-3,4-dihydro-2h-isoquinolin-1-one Chemical compound O=C1NCCC2=C1C=CC=C2F ZZGXLZYBHQFPQV-UHFFFAOYSA-N 0.000 description 2
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 description 2
- ZBNIQZCMPPVSKL-UHFFFAOYSA-N 6,7,8,9-tetrahydro-5h-benzo[7]annulen-5-ol Chemical compound OC1CCCCC2=CC=CC=C12 ZBNIQZCMPPVSKL-UHFFFAOYSA-N 0.000 description 2
- KWHUHTFXMNQHAA-UHFFFAOYSA-N 6,7,8,9-tetrahydrobenzo[7]annulen-5-one Chemical compound O=C1CCCCC2=CC=CC=C12 KWHUHTFXMNQHAA-UHFFFAOYSA-N 0.000 description 2
- NKFNEIYWSQIOLY-UHFFFAOYSA-N 7-methoxy-1,2,3,4-tetrahydronaphthalen-1-ol Chemical compound C1CCC(O)C2=CC(OC)=CC=C21 NKFNEIYWSQIOLY-UHFFFAOYSA-N 0.000 description 2
- JJDAWRNLQIOJMC-UHFFFAOYSA-N 9-(methoxymethyl)-1,2,3,4-tetrahydropyrido[3,4-b]indole Chemical compound C12=CC=CC=C2N(COC)C2=C1CCNC2 JJDAWRNLQIOJMC-UHFFFAOYSA-N 0.000 description 2
- NIVCAESKRVQXBZ-UHFFFAOYSA-N 9-propan-2-yl-1,2,3,4-tetrahydropyrido[3,4-b]indole;hydrochloride Chemical compound Cl.C12=CC=CC=C2N(C(C)C)C2=C1CCNC2 NIVCAESKRVQXBZ-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- CEIXWJHURKEBMQ-UHFFFAOYSA-N Heliamine Chemical compound C1CNCC2=C1C=C(OC)C(OC)=C2 CEIXWJHURKEBMQ-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MWDCNELMZRFPEA-UHFFFAOYSA-N [O-]C(=O)C(F)(F)F.C1=[NH+]C=C2SC=CC2=C1 Chemical compound [O-]C(=O)C(F)(F)F.C1=[NH+]C=C2SC=CC2=C1 MWDCNELMZRFPEA-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001266 acyl halides Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003849 aromatic solvent Substances 0.000 description 2
- 150000005130 benzoxazines Chemical class 0.000 description 2
- QVZDETYQBCKQGQ-UHFFFAOYSA-N benzyl 6-(2,2,2-trifluoroacetyl)-2,4,4a,5-tetrahydro-1h-pyrazino[1,2-a]quinoxaline-3-carboxylate Chemical compound C1CN2C3=CC=CC=C3N(C(=O)C(F)(F)F)CC2CN1C(=O)OCC1=CC=CC=C1 QVZDETYQBCKQGQ-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 2
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000007336 electrophilic substitution reaction Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- RERZNCLIYCABFS-UHFFFAOYSA-N harmaline Chemical compound C1CN=C(C)C2=C1C1=CC=C(OC)C=C1N2 RERZNCLIYCABFS-UHFFFAOYSA-N 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- QNLOWBMKUIXCOW-UHFFFAOYSA-N indol-2-one Chemical compound C1=CC=CC2=NC(=O)C=C21 QNLOWBMKUIXCOW-UHFFFAOYSA-N 0.000 description 2
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- FPCCSQOGAWCVBH-UHFFFAOYSA-N ketanserin Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(CCN2C(C3=CC=CC=C3NC2=O)=O)CC1 FPCCSQOGAWCVBH-UHFFFAOYSA-N 0.000 description 2
- 229960005417 ketanserin Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- QJBXIDGMNXAENX-UHFFFAOYSA-N methyl 1,2,3,4-tetrahydropyrido[3,4-b]indole-9-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(C(=O)OC)C2=C1CCNC2 QJBXIDGMNXAENX-UHFFFAOYSA-N 0.000 description 2
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 2
- ZNIXEVSMQRBBEM-UHFFFAOYSA-N methyl 3-fluoro-2-methylbenzoate Chemical compound COC(=O)C1=CC=CC(F)=C1C ZNIXEVSMQRBBEM-UHFFFAOYSA-N 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- QBPIDNWMEBXNOZ-UHFFFAOYSA-N morpholin-4-yl(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methanone Chemical compound C=1C=2CNCCC=2SC=1C(=O)N1CCOCC1 QBPIDNWMEBXNOZ-UHFFFAOYSA-N 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- WAFCDFXWCIATEV-UHFFFAOYSA-N n,n-diethyl-1,2,3,4-tetrahydropyrido[3,4-b]indole-9-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(C(=O)N(CC)CC)C2=C1CCNC2 WAFCDFXWCIATEV-UHFFFAOYSA-N 0.000 description 2
- XMKPBADOQMDELY-UHFFFAOYSA-N n-benzyl-2-chloro-n-(furan-3-ylmethyl)ethanamine Chemical compound C=1C=CC=CC=1CN(CCCl)CC=1C=COC=1 XMKPBADOQMDELY-UHFFFAOYSA-N 0.000 description 2
- LTDNALOFCQTDGS-UHFFFAOYSA-N n-methyl-1,2,3,4-tetrahydropyrido[3,4-b]indole-9-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(C(=O)NC)C2=C1CCNC2 LTDNALOFCQTDGS-UHFFFAOYSA-N 0.000 description 2
- GSJRUEBQWPLHSN-UHFFFAOYSA-N n-methylmethanamine;oxolane Chemical compound CNC.C1CCOC1 GSJRUEBQWPLHSN-UHFFFAOYSA-N 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000012285 osmium tetroxide Substances 0.000 description 2
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- QYMDEOQLJUUNOF-UHFFFAOYSA-N pinoline Chemical compound C1NCCC2=C1NC1=CC=C(OC)C=C12 QYMDEOQLJUUNOF-UHFFFAOYSA-N 0.000 description 2
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 201000000980 schizophrenia Diseases 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- FTIBIIQRTFOCKU-UHFFFAOYSA-N tert-butyl 2-(dimethylcarbamoyl)-6,7-dihydro-4h-thieno[3,2-c]pyridine-5-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC2=C1C=C(C(=O)N(C)C)S2 FTIBIIQRTFOCKU-UHFFFAOYSA-N 0.000 description 2
- GDBLVYAUPNQGLX-UHFFFAOYSA-N tert-butyl 2-(morpholine-4-carbonyl)-6,7-dihydro-4h-thieno[3,2-c]pyridine-5-carboxylate Chemical compound C=1C=2CN(C(=O)OC(C)(C)C)CCC=2SC=1C(=O)N1CCOCC1 GDBLVYAUPNQGLX-UHFFFAOYSA-N 0.000 description 2
- WMKIJUGTZNCUGS-UHFFFAOYSA-N tert-butyl 2-methyl-6,7-dihydro-4h-thieno[3,2-c]pyridine-5-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC2=C1C=C(C)S2 WMKIJUGTZNCUGS-UHFFFAOYSA-N 0.000 description 2
- XKQYXBJGGJFVTI-UHFFFAOYSA-N tert-butyl 4-(1,2,3,4-tetrahydronaphthalen-1-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1C2=CC=CC=C2CCC1 XKQYXBJGGJFVTI-UHFFFAOYSA-N 0.000 description 2
- VHUZTMWZJJEDSH-UHFFFAOYSA-N tert-butyl 4-(1-phenylethyl)piperazine-1-carboxylate Chemical compound C=1C=CC=CC=1C(C)N1CCN(C(=O)OC(C)(C)C)CC1 VHUZTMWZJJEDSH-UHFFFAOYSA-N 0.000 description 2
- LVQINCFYBNICFN-UHFFFAOYSA-N tert-butyl 4-(5,6,7,8-tetrahydroisoquinolin-5-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1C2=CC=NC=C2CCC1 LVQINCFYBNICFN-UHFFFAOYSA-N 0.000 description 2
- QUVMORDMIXPNQY-UHFFFAOYSA-N tert-butyl 4-(5,6,7,8-tetrahydroquinolin-8-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1C2=NC=CC=C2CCC1 QUVMORDMIXPNQY-UHFFFAOYSA-N 0.000 description 2
- OYWWVJOCHKUCCD-UHFFFAOYSA-N tert-butyl 4-(5-oxo-6,7,8,9-tetrahydrobenzo[7]annulen-9-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1C2=CC=CC=C2C(=O)CCC1 OYWWVJOCHKUCCD-UHFFFAOYSA-N 0.000 description 2
- NPUBWBLLXPSYQM-UHFFFAOYSA-N tert-butyl 4-(7-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)piperazine-1-carboxylate Chemical compound C12=CC(OC)=CC=C2CCCC1N1CCN(C(=O)OC(C)(C)C)CC1 NPUBWBLLXPSYQM-UHFFFAOYSA-N 0.000 description 2
- DPEQXCDBCMRTGN-UHFFFAOYSA-N tert-butyl 6,7-dihydroxy-1-methyl-3,4-dihydro-1h-isoquinoline-2-carboxylate Chemical compound OC1=C(O)C=C2C(C)N(C(=O)OC(C)(C)C)CCC2=C1 DPEQXCDBCMRTGN-UHFFFAOYSA-N 0.000 description 2
- MFXHRPOAIOBJIE-UHFFFAOYSA-N tert-butyl 9-(2-acetyloxyethyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(CCOC(=O)C)C2=C1CCN(C(=O)OC(C)(C)C)C2 MFXHRPOAIOBJIE-UHFFFAOYSA-N 0.000 description 2
- UGPQJNQXWDLXRL-UHFFFAOYSA-N tert-butyl 9-(2-amino-2-oxoethyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound NC(=O)CN1C2=CC=CC=C2C2=C1CN(C(=O)OC(C)(C)C)CC2 UGPQJNQXWDLXRL-UHFFFAOYSA-N 0.000 description 2
- DMZZDPJXWVNTNN-UHFFFAOYSA-N tert-butyl 9-(2-oxopropyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(CC(=O)C)C2=C1CCN(C(=O)OC(C)(C)C)C2 DMZZDPJXWVNTNN-UHFFFAOYSA-N 0.000 description 2
- IHSOMTNHPMNCHB-UHFFFAOYSA-N tert-butyl 9-(diethylcarbamoyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(C(=O)N(CC)CC)C2=C1CCN(C(=O)OC(C)(C)C)C2 IHSOMTNHPMNCHB-UHFFFAOYSA-N 0.000 description 2
- PXGISSSWOQHYKC-UHFFFAOYSA-N tert-butyl 9-(dimethylcarbamoyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(C(=O)N(C)C)C2=C1CCN(C(=O)OC(C)(C)C)C2 PXGISSSWOQHYKC-UHFFFAOYSA-N 0.000 description 2
- FNVKUFZOQHVNKW-UHFFFAOYSA-N tert-butyl 9-(methoxymethyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(COC)C2=C1CCN(C(=O)OC(C)(C)C)C2 FNVKUFZOQHVNKW-UHFFFAOYSA-N 0.000 description 2
- ZEEPAWDCVUITOJ-UHFFFAOYSA-N tert-butyl 9-(methylcarbamoyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(C(=O)NC)C2=C1CCN(C(=O)OC(C)(C)C)C2 ZEEPAWDCVUITOJ-UHFFFAOYSA-N 0.000 description 2
- NCDPBKRHARSTAX-UHFFFAOYSA-N tert-butyl 9-[2-(dimethylamino)-2-oxoethyl]-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(CC(=O)N(C)C)C2=C1CCN(C(=O)OC(C)(C)C)C2 NCDPBKRHARSTAX-UHFFFAOYSA-N 0.000 description 2
- SUJUERLBBIRWPZ-UHFFFAOYSA-N tert-butyl 9-acetyl-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(C(=O)C)C2=C1CCN(C(=O)OC(C)(C)C)C2 SUJUERLBBIRWPZ-UHFFFAOYSA-N 0.000 description 2
- DLBSVUIHZJSLMT-UHFFFAOYSA-N tert-butyl 9-benzyl-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC(C2=CC=CC=C22)=C1N2CC1=CC=CC=C1 DLBSVUIHZJSLMT-UHFFFAOYSA-N 0.000 description 2
- UZXAKNSTLHWZRX-UHFFFAOYSA-N tert-butyl 9-carbamoyl-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound NC(=O)N1C2=CC=CC=C2C2=C1CN(C(=O)OC(C)(C)C)CC2 UZXAKNSTLHWZRX-UHFFFAOYSA-N 0.000 description 2
- KZJNIEOORDJITI-UHFFFAOYSA-N tert-butyl 9-methyl-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(C)C2=C1CCN(C(=O)OC(C)(C)C)C2 KZJNIEOORDJITI-UHFFFAOYSA-N 0.000 description 2
- RSAGSUMROALRRZ-UHFFFAOYSA-N tert-butyl n-(3,4-dihydro-2h-1,4-benzothiazin-3-ylmethyl)carbamate Chemical compound C1=CC=C2NC(CNC(=O)OC(C)(C)C)CSC2=C1 RSAGSUMROALRRZ-UHFFFAOYSA-N 0.000 description 2
- RCLVCCSIVMNZTF-UHFFFAOYSA-N tert-butyl n-[[4-(2-chloroacetyl)-2,3-dihydro-1,4-benzothiazin-3-yl]methyl]carbamate Chemical compound C1=CC=C2N(C(=O)CCl)C(CNC(=O)OC(C)(C)C)CSC2=C1 RCLVCCSIVMNZTF-UHFFFAOYSA-N 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000005270 trialkylamine group Chemical group 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 1
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical class COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 1
- ZGRLKUNDSJJMKD-UHFFFAOYSA-N 1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;hydrochloride Chemical compound Cl.C1=CC=C2N3CCNCC3COC2=C1 ZGRLKUNDSJJMKD-UHFFFAOYSA-N 0.000 description 1
- FRZDVWUAWCOHDI-UHFFFAOYSA-N 1,2,3,4,4a,6-hexahydropyrazino[1,2-a]quinoxalin-5-one Chemical group C1CNCC2C(=O)NC3=CC=CC=C3N21 FRZDVWUAWCOHDI-UHFFFAOYSA-N 0.000 description 1
- JAAJQSRLGAYGKZ-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-ol Chemical compound C1=CC=C2C(O)CCCC2=C1 JAAJQSRLGAYGKZ-UHFFFAOYSA-N 0.000 description 1
- HRVRAYIYXRVAPR-UHFFFAOYSA-N 1,3,4,5-tetrahydro-1-benzazepin-2-one Chemical compound N1C(=O)CCCC2=CC=CC=C21 HRVRAYIYXRVAPR-UHFFFAOYSA-N 0.000 description 1
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 1
- DLLBLNFCUXJHHV-UHFFFAOYSA-N 1-(1,2,3,4-tetrahydronaphthalen-1-yl)piperazine Chemical compound C12=CC=CC=C2CCCC1N1CCNCC1 DLLBLNFCUXJHHV-UHFFFAOYSA-N 0.000 description 1
- ABMZSHYXRIBZEZ-UHFFFAOYSA-N 1-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)ethanone;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(C(=O)C)C2=C1CCNC2 ABMZSHYXRIBZEZ-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- UZKBSZSTDQSMDR-UHFFFAOYSA-N 1-[(4-chlorophenyl)-phenylmethyl]piperazine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)N1CCNCC1 UZKBSZSTDQSMDR-UHFFFAOYSA-N 0.000 description 1
- AWNXKZVIZARMME-UHFFFAOYSA-N 1-[[5-[2-[(2-chloropyridin-4-yl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol Chemical compound N=1C(NCC(C)(O)C)=NC=C(C=2N=C(NC=3C=C(Cl)N=CC=3)N=CC=2)C=1CC1CC1 AWNXKZVIZARMME-UHFFFAOYSA-N 0.000 description 1
- MGKPCLNUSDGXGT-UHFFFAOYSA-N 1-benzofuran-3-one Chemical compound C1=CC=C2C(=O)COC2=C1 MGKPCLNUSDGXGT-UHFFFAOYSA-N 0.000 description 1
- DIRTUFVVQCBEDV-UHFFFAOYSA-N 1-benzyl-4-(2-phenylpropan-2-yl)piperazine Chemical compound C=1C=CC=CC=1C(C)(C)N(CC1)CCN1CC1=CC=CC=C1 DIRTUFVVQCBEDV-UHFFFAOYSA-N 0.000 description 1
- MLEGMEBCXGDFQT-UHFFFAOYSA-N 1-benzylpiperidin-2-one Chemical compound O=C1CCCCN1CC1=CC=CC=C1 MLEGMEBCXGDFQT-UHFFFAOYSA-N 0.000 description 1
- HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 1
- WSXIDSNEEOYBFA-UHFFFAOYSA-N 1-bromopent-1-ene Chemical compound CCCC=CBr WSXIDSNEEOYBFA-UHFFFAOYSA-N 0.000 description 1
- UWDCUCCPBLHLTI-UHFFFAOYSA-N 1-fluoropyridin-1-ium Chemical class F[N+]1=CC=CC=C1 UWDCUCCPBLHLTI-UHFFFAOYSA-N 0.000 description 1
- OGMGXKJQIOUTTB-UHFFFAOYSA-N 1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrobromide Chemical compound Br.OC1=C(O)C=C2C(C)NCCC2=C1 OGMGXKJQIOUTTB-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- LLWVQXHVPIIHDZ-UHFFFAOYSA-N 1-methyl-2a,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC3=C2C1C(=O)N3C LLWVQXHVPIIHDZ-UHFFFAOYSA-N 0.000 description 1
- BEUJAVGQOANFRI-UHFFFAOYSA-N 1h-indole;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC=C2NC=CC2=C1 BEUJAVGQOANFRI-UHFFFAOYSA-N 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- SIQBPWRTJNBBER-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-2-benzazepine Chemical compound C1CCNCC2=CC=CC=C21 SIQBPWRTJNBBER-UHFFFAOYSA-N 0.000 description 1
- CFTOTSJVQRFXOF-JZRMKITLSA-N 2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole Chemical class N1C2=CC=CC=C2C2=C1[11CH2]NCC2 CFTOTSJVQRFXOF-JZRMKITLSA-N 0.000 description 1
- CVQSWZMJOGOPAV-UHFFFAOYSA-N 2,3-dihydrothiochromen-4-one Chemical compound C1=CC=C2C(=O)CCSC2=C1 CVQSWZMJOGOPAV-UHFFFAOYSA-N 0.000 description 1
- NNPSOAOENINXMR-UHFFFAOYSA-N 2,3-dimethyl-2,3-dihydro-1h-indole Chemical compound C1=CC=C2C(C)C(C)NC2=C1 NNPSOAOENINXMR-UHFFFAOYSA-N 0.000 description 1
- ULCHUSIKHCWCSZ-UHFFFAOYSA-N 2-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(CC(=O)N)C2=C1CCNC2 ULCHUSIKHCWCSZ-UHFFFAOYSA-N 0.000 description 1
- GYLGMZAXBOCBSQ-UHFFFAOYSA-N 2-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)ethyl acetate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(CCOC(=O)C)C2=C1CCNC2 GYLGMZAXBOCBSQ-UHFFFAOYSA-N 0.000 description 1
- BJAJKVZABJZXDC-UHFFFAOYSA-N 2-(1-benzofuran-3-yl)acetonitrile Chemical compound C1=CC=C2C(CC#N)=COC2=C1 BJAJKVZABJZXDC-UHFFFAOYSA-N 0.000 description 1
- DVADEBQIGFNXNC-UHFFFAOYSA-N 2-[2-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-3,4-dihydro-1h-pyrido[3,4-b]indol-9-yl]acetonitrile Chemical compound N#CCN1C2=CC=CC=C2C(CC2)=C1CN2CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 DVADEBQIGFNXNC-UHFFFAOYSA-N 0.000 description 1
- VWUKDNSEDPMMFR-UHFFFAOYSA-N 2-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-3,4-dihydro-1h-pyrido[3,4-b]indole-9-carboxamide Chemical compound C12=CC=CC=C2N(C(=O)N)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 VWUKDNSEDPMMFR-UHFFFAOYSA-N 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- RGHQKFQZGLKBCF-UHFFFAOYSA-N 2-bromoethyl acetate Chemical compound CC(=O)OCCBr RGHQKFQZGLKBCF-UHFFFAOYSA-N 0.000 description 1
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 1
- PXFVJRYQSXKFJX-UHFFFAOYSA-N 2-methyl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine Chemical compound C1NCCC2=NN(C)C=C21 PXFVJRYQSXKFJX-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- DMWUYLTUCJIKFV-UHFFFAOYSA-N 2a-[3-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)propyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound N1C2=CC=CC=C2C(CC2)=C1CN2CCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 DMWUYLTUCJIKFV-UHFFFAOYSA-N 0.000 description 1
- FDHWGBQQOFQIKJ-UHFFFAOYSA-N 2a-[4-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound N1C2=CC=CC=C2C(CC2)=C1CN2CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 FDHWGBQQOFQIKJ-UHFFFAOYSA-N 0.000 description 1
- RTLYDCLNWRVYQW-UHFFFAOYSA-N 2a-[4-(1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound O=C1NC(C2=3)=CC=CC=3CCCC12CCCCN(C1)CCC2=C1C=NN2 RTLYDCLNWRVYQW-UHFFFAOYSA-N 0.000 description 1
- WUGZCZDBNJRMIS-UHFFFAOYSA-N 2a-[4-(2,3-dimethyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-5-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCC1NCC(SC(=C2C)C)=C2C1 WUGZCZDBNJRMIS-UHFFFAOYSA-N 0.000 description 1
- QBBSYFPUMYVOEE-UHFFFAOYSA-N 2a-[4-(2,4,4a,5-tetrahydro-1h-pyrazino[2,1-c][1,4]benzothiazin-3-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1C2CSC3=CC=CC=C3N2CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 QBBSYFPUMYVOEE-UHFFFAOYSA-N 0.000 description 1
- ZEJVRNLENIYKIL-UHFFFAOYSA-N 2a-[4-(2-methyl-6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN1CC(C=C(S2)C)=C2CC1 ZEJVRNLENIYKIL-UHFFFAOYSA-N 0.000 description 1
- JHEHDPXSLYHDAB-UHFFFAOYSA-N 2a-[4-(3,4-dihydro-1h-isoquinolin-2-yl)butyl]-1-ethyl-4,5-dihydro-3h-benzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC3=C2C1(CCCCN1CC2=CC=CC=C2CC1)C(=O)N3CC JHEHDPXSLYHDAB-UHFFFAOYSA-N 0.000 description 1
- YIPRVVVARXKUOR-UHFFFAOYSA-N 2a-[4-(3-methyl-6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN1CCC(SC=C2C)=C2C1 YIPRVVVARXKUOR-UHFFFAOYSA-N 0.000 description 1
- ZIMYOHPDDZSLCP-UHFFFAOYSA-N 2a-[4-(4-benzylpiperazin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound O=C1NC(C2=3)=CC=CC=3CCCC12CCCCN(CC1)CCN1CC1=CC=CC=C1 ZIMYOHPDDZSLCP-UHFFFAOYSA-N 0.000 description 1
- IGYDTTJVYFLZMJ-UHFFFAOYSA-N 2a-[4-(5,7-dihydro-4h-thieno[2,3-c]pyridin-6-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound O=C1NC(C2=3)=CC=CC=3CCCC12CCCCN(C1)CCC2=C1SC=C2 IGYDTTJVYFLZMJ-UHFFFAOYSA-N 0.000 description 1
- CTGTXVHAPZSAFB-UHFFFAOYSA-N 2a-[4-(5-fluoro-3,4-dihydro-1h-isoquinolin-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN1CC(C=CC=C2F)=C2CC1 CTGTXVHAPZSAFB-UHFFFAOYSA-N 0.000 description 1
- HYPWGIMZDOLBLN-UHFFFAOYSA-N 2a-[4-(6,7-dihydro-4h-furo[3,2-c]pyridin-5-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound O=C1NC(C2=3)=CC=CC=3CCCC12CCCCN(C1)CCC2=C1C=CO2 HYPWGIMZDOLBLN-UHFFFAOYSA-N 0.000 description 1
- PSWCYJDXBLJOMH-UHFFFAOYSA-N 2a-[4-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound O=C1NC(C2=3)=CC=CC=3CCCC12CCCCN(C1)CCC2=C1C=CS2 PSWCYJDXBLJOMH-UHFFFAOYSA-N 0.000 description 1
- ACCXXSBGCCOECP-UHFFFAOYSA-N 2a-[4-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)butyl]-1-ethyl-4,5-dihydro-3h-benzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC3=C2C1(CCCCN1CC=2C=CSC=2CC1)C(=O)N3CC ACCXXSBGCCOECP-UHFFFAOYSA-N 0.000 description 1
- NKBNPAVRJIVQDG-UHFFFAOYSA-N 2a-[4-(6,7-dimethoxy-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN1CCC(C=C(C(=C2)OC)OC)=C2C1C NKBNPAVRJIVQDG-UHFFFAOYSA-N 0.000 description 1
- RYTJTOGZJOWSHG-UHFFFAOYSA-N 2a-[4-(6-hydroxy-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN1CC(NC2=CC=C(C=C22)O)=C2CC1 RYTJTOGZJOWSHG-UHFFFAOYSA-N 0.000 description 1
- HIERSXGFUPMUMD-UHFFFAOYSA-N 2a-[4-(6-methoxy-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN1CC(NC2=CC=C(C=C22)OC)=C2CC1 HIERSXGFUPMUMD-UHFFFAOYSA-N 0.000 description 1
- FNLVSYVCTGWSJL-UHFFFAOYSA-N 2a-[4-(9-acetyl-3,4-dihydro-1h-pyrido[3,4-b]indol-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C12=CC=CC=C2N(C(=O)C)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 FNLVSYVCTGWSJL-UHFFFAOYSA-N 0.000 description 1
- DEAYIVIBPAQZTC-UHFFFAOYSA-N 2a-[4-(9-benzyl-3,4-dihydro-1h-pyrido[3,4-b]indol-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound O=C1NC(C2=3)=CC=CC=3CCCC12CCCCN(C1)CCC(C2=CC=CC=C22)=C1N2CC1=CC=CC=C1 DEAYIVIBPAQZTC-UHFFFAOYSA-N 0.000 description 1
- AQPAEUIJRBRZNA-UHFFFAOYSA-N 2a-[4-(9-methyl-3,4-dihydro-1h-pyrido[3,4-b]indol-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C12=CC=CC=C2N(C)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 AQPAEUIJRBRZNA-UHFFFAOYSA-N 0.000 description 1
- VWLFNRQOYFQCTL-UHFFFAOYSA-N 2a-[4-(9-propan-2-yl-3,4-dihydro-1h-pyrido[3,4-b]indol-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C12=CC=CC=C2N(C(C)C)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 VWLFNRQOYFQCTL-UHFFFAOYSA-N 0.000 description 1
- LVWGARUEIWPFHE-UHFFFAOYSA-N 2a-[4-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC=C2C1N(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 LVWGARUEIWPFHE-UHFFFAOYSA-N 0.000 description 1
- FTRXLNMUMKNABI-UHFFFAOYSA-N 2a-[4-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)piperidin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC=C2C1C(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 FTRXLNMUMKNABI-UHFFFAOYSA-N 0.000 description 1
- LASYGKVLZHCNSR-UHFFFAOYSA-N 2a-[4-[4-(1-phenylethyl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CN(CCCCC23C(NC=4C=CC=C(C3=4)CCC2)=O)CCN1C(C)C1=CC=CC=C1 LASYGKVLZHCNSR-UHFFFAOYSA-N 0.000 description 1
- XLWSDZBXXPZYTI-UHFFFAOYSA-N 2a-[4-[4-(2,3-dihydro-1h-inden-1-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CC2=CC=CC=C2C1N(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 XLWSDZBXXPZYTI-UHFFFAOYSA-N 0.000 description 1
- ASYWKPWDEWMLGE-UHFFFAOYSA-N 2a-[4-[4-(2-phenylpropan-2-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CN(CCCCC23C(NC=4C=CC=C(C3=4)CCC2)=O)CCN1C(C)(C)C1=CC=CC=C1 ASYWKPWDEWMLGE-UHFFFAOYSA-N 0.000 description 1
- RZPVYONZMVKUPR-UHFFFAOYSA-N 2a-[4-[4-(3,4-dihydro-1h-isoquinolin-2-yl)piperidin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CC2=CC=CC=C2CN1C(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 RZPVYONZMVKUPR-UHFFFAOYSA-N 0.000 description 1
- UQUWGGRHWUNWEY-UHFFFAOYSA-N 2a-[4-[4-(3,4-dihydro-2h-chromen-4-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1COC2=CC=CC=C2C1N(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 UQUWGGRHWUNWEY-UHFFFAOYSA-N 0.000 description 1
- VOMBPWMWAQUVPY-UHFFFAOYSA-N 2a-[4-[4-(3,4-dihydro-2h-thiochromen-4-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CSC2=CC=CC=C2C1N(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 VOMBPWMWAQUVPY-UHFFFAOYSA-N 0.000 description 1
- AKQFDZGPKAQOAQ-UHFFFAOYSA-N 2a-[4-[4-(5,6,7,8-tetrahydroisoquinolin-5-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CN=CC=C2C1N(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 AKQFDZGPKAQOAQ-UHFFFAOYSA-N 0.000 description 1
- NRKMJVFYEJLVSM-UHFFFAOYSA-N 2a-[4-[4-(5,6,7,8-tetrahydroquinolin-8-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CN=C2C1N(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 NRKMJVFYEJLVSM-UHFFFAOYSA-N 0.000 description 1
- REUPTHJVJFTFOF-UHFFFAOYSA-N 2a-[4-[4-(5-oxo-6,7,8,9-tetrahydrobenzo[7]annulen-9-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC(=O)C2=CC=CC=C2C1N(CC1)CCN1CCCCC1(C(=O)N2)CCCC3=C1C2=CC=C3 REUPTHJVJFTFOF-UHFFFAOYSA-N 0.000 description 1
- FQSMCRWKKQQYGM-UHFFFAOYSA-N 2a-[4-[4-(7-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN(CC1)CCN1C1CCCC2=CC=C(OC)C=C21 FQSMCRWKKQQYGM-UHFFFAOYSA-N 0.000 description 1
- GPNDTWVUURBCBH-UHFFFAOYSA-N 2a-[4-[9-(2-hydroxyethyl)-3,4-dihydro-1h-pyrido[3,4-b]indol-2-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C12=CC=CC=C2N(CCO)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 GPNDTWVUURBCBH-UHFFFAOYSA-N 0.000 description 1
- CRRKLNGYPLRVMF-UHFFFAOYSA-N 2a-[4-[9-(methoxymethyl)-3,4-dihydro-1h-pyrido[3,4-b]indol-2-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C12=CC=CC=C2N(COC)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 CRRKLNGYPLRVMF-UHFFFAOYSA-N 0.000 description 1
- AHLXYZLFKAUGCX-UHFFFAOYSA-N 2a-pent-4-enyl-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound C1CCC2=CC=CC3=C2C1(CCCC=C)C(=O)N3 AHLXYZLFKAUGCX-UHFFFAOYSA-N 0.000 description 1
- HGENHKQBSARIQT-UHFFFAOYSA-N 2h-pyrazino[2,3-h][1,2]benzoxazine Chemical class C1=CC2=NC=CN=C2C2=C1C=CNO2 HGENHKQBSARIQT-UHFFFAOYSA-N 0.000 description 1
- WVFRBEVHVKERPG-UHFFFAOYSA-N 3,4-dihydro-2h-1,4-benzothiazin-3-ylmethanamine Chemical compound C1=CC=C2NC(CN)CSC2=C1 WVFRBEVHVKERPG-UHFFFAOYSA-N 0.000 description 1
- FWVSZXYNCFXKRT-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromen-4-ol Chemical compound C1=CC=C2C(O)CCSC2=C1 FWVSZXYNCFXKRT-UHFFFAOYSA-N 0.000 description 1
- XMKZAIHFVHJGPV-UHFFFAOYSA-N 3-fluoro-2-methylbenzoic acid Chemical compound CC1=C(F)C=CC=C1C(O)=O XMKZAIHFVHJGPV-UHFFFAOYSA-N 0.000 description 1
- RBIGKSZIQCTIJF-UHFFFAOYSA-N 3-formylthiophene Chemical compound O=CC=1C=CSC=1 RBIGKSZIQCTIJF-UHFFFAOYSA-N 0.000 description 1
- AZVSIHIBYRHSLB-UHFFFAOYSA-N 3-furaldehyde Chemical compound O=CC=1C=COC=1 AZVSIHIBYRHSLB-UHFFFAOYSA-N 0.000 description 1
- SKNBYROUCJKRDB-UHFFFAOYSA-N 3-methyl-4,5,6,7-tetrahydro-2h-pyrazolo[4,3-c]pyridine Chemical compound C1CNCC2=C1NN=C2C SKNBYROUCJKRDB-UHFFFAOYSA-N 0.000 description 1
- OBFVQLRWLPFYED-UHFFFAOYSA-N 3-methyl-5-[(2-methylpropan-2-yl)oxycarbonyl]-6,7-dihydro-4h-thieno[3,2-c]pyridine-2-carboxylic acid Chemical compound C1N(C(=O)OC(C)(C)C)CCC2=C1C(C)=C(C(O)=O)S2 OBFVQLRWLPFYED-UHFFFAOYSA-N 0.000 description 1
- NWCYECXHIYEBJE-UHFFFAOYSA-N 3-oxobutyl acetate Chemical compound CC(=O)CCOC(C)=O NWCYECXHIYEBJE-UHFFFAOYSA-N 0.000 description 1
- VGMJQHONPAXABH-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridine Chemical compound C1NCCC2=C1C=NN2 VGMJQHONPAXABH-UHFFFAOYSA-N 0.000 description 1
- URMVFILWXLQJIP-UHFFFAOYSA-N 4,5,6,7-tetrahydro-3h-imidazo[4,5-c]pyridine Chemical compound C1NCCC2=C1NC=N2 URMVFILWXLQJIP-UHFFFAOYSA-N 0.000 description 1
- ZDKHUQDELHMHFD-UHFFFAOYSA-N 4,5,6,7-tetrahydrothieno[2,3-c]pyridine-2-carboxylic acid Chemical compound C1CNCC2=C1C=C(C(=O)O)S2 ZDKHUQDELHMHFD-UHFFFAOYSA-N 0.000 description 1
- OEYJTWUFGQRSOD-UHFFFAOYSA-N 4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-ium-2-carboxylate Chemical compound C1NCCC2=C1C=C(C(=O)O)S2 OEYJTWUFGQRSOD-UHFFFAOYSA-N 0.000 description 1
- MWZDFPMMKQJYFB-UHFFFAOYSA-N 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1NCCC2=C1C=C(C(=O)O)S2 MWZDFPMMKQJYFB-UHFFFAOYSA-N 0.000 description 1
- CUUPTAYSCIOICO-UHFFFAOYSA-N 4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butanal Chemical compound C1CCC2=CC=CC3=C2C1(CCCC=O)C(=O)N3 CUUPTAYSCIOICO-UHFFFAOYSA-N 0.000 description 1
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical compound C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 description 1
- ABGXADJDTPFFSZ-UHFFFAOYSA-N 4-benzylpiperidine Chemical compound C=1C=CC=CC=1CC1CCNCC1 ABGXADJDTPFFSZ-UHFFFAOYSA-N 0.000 description 1
- MPZMVUQGXAOJIK-UHFFFAOYSA-N 4-bromopyridine;hydron;chloride Chemical compound Cl.BrC1=CC=NC=C1 MPZMVUQGXAOJIK-UHFFFAOYSA-N 0.000 description 1
- YRKLJYRHSRRSMH-UHFFFAOYSA-N 5,6,7,8-tetrahydro-4h-furo[2,3-c]azepine Chemical compound C1CCNCC2=C1C=CO2 YRKLJYRHSRRSMH-UHFFFAOYSA-N 0.000 description 1
- ZFSYBODWGHEZST-UHFFFAOYSA-N 5,6,7,8-tetrahydro-4h-furo[2,3-d]azepine Chemical compound C1CNCCC2=C1OC=C2 ZFSYBODWGHEZST-UHFFFAOYSA-N 0.000 description 1
- GVLUAKKYTJQALV-UHFFFAOYSA-N 5,6,7,8-tetrahydro-4h-thieno[2,3-c]azepine-2-carboxylic acid Chemical compound C1CCNCC2=C1C=C(C(=O)O)S2 GVLUAKKYTJQALV-UHFFFAOYSA-N 0.000 description 1
- RCTKBWSGKTWLFI-UHFFFAOYSA-N 5,6,7,8-tetrahydro-4h-thieno[3,2-c]azepine-2-carboxylic acid Chemical compound C1NCCCC2=C1C=C(C(=O)O)S2 RCTKBWSGKTWLFI-UHFFFAOYSA-N 0.000 description 1
- HTMGQIXFZMZZKD-UHFFFAOYSA-N 5,6,7,8-tetrahydroisoquinoline Chemical compound N1=CC=C2CCCCC2=C1 HTMGQIXFZMZZKD-UHFFFAOYSA-N 0.000 description 1
- 102000056834 5-HT2 Serotonin Receptors Human genes 0.000 description 1
- 108091005479 5-HT2 receptors Proteins 0.000 description 1
- RYYDMZOUDODRDJ-UHFFFAOYSA-N 5-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-6,7-dihydro-4h-thieno[3,2-c]pyridine-2-carboxamide Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN1CC(C=C(S2)C(=O)N)=C2CC1 RYYDMZOUDODRDJ-UHFFFAOYSA-N 0.000 description 1
- 102100040368 5-hydroxytryptamine receptor 6 Human genes 0.000 description 1
- 101710150235 5-hydroxytryptamine receptor 6 Proteins 0.000 description 1
- IFDIAPORDJTSKP-UHFFFAOYSA-N 5-methoxynaphthalene-1-carbonitrile Chemical compound C1=CC=C2C(OC)=CC=CC2=C1C#N IFDIAPORDJTSKP-UHFFFAOYSA-N 0.000 description 1
- QGELVLBHMKUSTG-UHFFFAOYSA-N 6-bromo-2a-[4-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one Chemical compound N1C2=CC=CC=C2C(CC2)=C1CN2CCCCC1(CCC2)C(=O)NC3=CC=C(Br)C2=C31 QGELVLBHMKUSTG-UHFFFAOYSA-N 0.000 description 1
- BDCCXYVTXRUGAN-UHFFFAOYSA-N 6-fluoro-2-methyl-1,2,3,4-tetrahydroquinoline Chemical compound FC1=CC=C2NC(C)CCC2=C1 BDCCXYVTXRUGAN-UHFFFAOYSA-N 0.000 description 1
- PTENEIBPTFISMR-UHFFFAOYSA-N 6-methyl-2,3,4,4a-tetrahydro-1h-pyrazino[1,2-a]quinoxalin-5-one;hydrochloride Chemical compound Cl.C12=CC=CC=C2N(C)C(=O)C2N1CCNC2 PTENEIBPTFISMR-UHFFFAOYSA-N 0.000 description 1
- GABLTKRIYDNDIN-UHFFFAOYSA-N 7-methoxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1CCC(=O)C2=CC(OC)=CC=C21 GABLTKRIYDNDIN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 1
- SROMRGBJXFAAJU-UHFFFAOYSA-N 9-benzyl-1,2,3,4-tetrahydropyrido[3,4-b]indole Chemical compound C1=2CNCCC=2C2=CC=CC=C2N1CC1=CC=CC=C1 SROMRGBJXFAAJU-UHFFFAOYSA-N 0.000 description 1
- ICUPRAORSPYZJU-UHFFFAOYSA-N 9-benzyl-1,2,3,4-tetrahydropyrido[3,4-b]indole;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=2CNCCC=2C2=CC=CC=C2N1CC1=CC=CC=C1 ICUPRAORSPYZJU-UHFFFAOYSA-N 0.000 description 1
- LISMJSXHYGUASA-UHFFFAOYSA-N 9-methyl-1,2,3,4-tetrahydropyrido[3,4-b]indole;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(C)C2=C1CCNC2 LISMJSXHYGUASA-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 101100219382 Caenorhabditis elegans cah-2 gene Proteins 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IXLJAHJIOOPXAR-UHFFFAOYSA-K F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.[O-]C(=O)C1=CC=CO1.[O-]C(=O)C1=CC=CO1.[O-]C(=O)C1=CC=CO1 Chemical compound F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.[O-]C(=O)C1=CC=CO1.[O-]C(=O)C1=CC=CO1.[O-]C(=O)C1=CC=CO1 IXLJAHJIOOPXAR-UHFFFAOYSA-K 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 238000006929 Pictet-Spengler synthesis reaction Methods 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000007281 aminoalkylation reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- ANTGQBPGYZDWAW-UHFFFAOYSA-N azane;1,4-dioxane Chemical compound N.C1COCCO1 ANTGQBPGYZDWAW-UHFFFAOYSA-N 0.000 description 1
- 125000004321 azepin-2-yl group Chemical group [H]N1C([H])=C([H])C([H])=C([H])C([H])=C1* 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- YROCJIFUJHOTPE-UHFFFAOYSA-N benzyl 4-(3,4-dihydro-1h-isoquinolin-2-yl)piperidine-1-carboxylate Chemical compound C1CC(N2CC3=CC=CC=C3CC2)CCN1C(=O)OCC1=CC=CC=C1 YROCJIFUJHOTPE-UHFFFAOYSA-N 0.000 description 1
- GIZBAAGXMPSCPZ-UHFFFAOYSA-N benzyl 5-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-6,7-dihydro-4h-thieno[3,2-c]pyridine-2-carboxylate Chemical compound C=1C=2CN(CCCCC34C(NC=5C=CC=C(C4=5)CCC3)=O)CCC=2SC=1C(=O)OCC1=CC=CC=C1 GIZBAAGXMPSCPZ-UHFFFAOYSA-N 0.000 description 1
- WCGBEFSZJSHDDX-UHFFFAOYSA-N benzyl 5-oxo-2,4,4a,6-tetrahydro-1h-pyrazino[1,2-a]quinoxaline-3-carboxylate Chemical compound C1CN(C2=CC=CC=C2NC2=O)C2CN1C(=O)OCC1=CC=CC=C1 WCGBEFSZJSHDDX-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229920005557 bromobutyl Polymers 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 238000005810 carbonylation reaction Methods 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000003403 chloroformylation reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- MPTQRFCYZCXJFQ-UHFFFAOYSA-L copper(II) chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Cu+2] MPTQRFCYZCXJFQ-UHFFFAOYSA-L 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- IGMWDYQIKLLYQH-UHFFFAOYSA-N cyanomethyl diethyl phosphate Chemical compound CCOP(=O)(OCC)OCC#N IGMWDYQIKLLYQH-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000005949 ethanesulfonyloxy group Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- LLGOMIPFKKCDSD-UHFFFAOYSA-N ethyl 3-oxo-4-phenylsulfanylbutanoate Chemical compound CCOC(=O)CC(=O)CSC1=CC=CC=C1 LLGOMIPFKKCDSD-UHFFFAOYSA-N 0.000 description 1
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 description 1
- WDCDAAMJNUHOIY-UHFFFAOYSA-N ethyl acetate;2-propan-2-yloxypropane Chemical compound CCOC(C)=O.CC(C)OC(C)C WDCDAAMJNUHOIY-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- PPZMYIBUHIPZOS-UHFFFAOYSA-N histamine dihydrochloride Chemical compound Cl.Cl.NCCC1=CN=CN1 PPZMYIBUHIPZOS-UHFFFAOYSA-N 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 1
- WZHJKEUHNJHDLS-QTGUNEKASA-N metergoline Chemical compound C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4N(C)C=C(C=34)C2)C1)C)NC(=O)OCC1=CC=CC=C1 WZHJKEUHNJHDLS-QTGUNEKASA-N 0.000 description 1
- 229960004650 metergoline Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- RHMQNXNXUZLEIY-UHFFFAOYSA-N methanol;2-propan-2-yloxypropane Chemical compound OC.CC(C)OC(C)C RHMQNXNXUZLEIY-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- DEHZQOLNSNVIHK-UHFFFAOYSA-N methyl 2-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)acetate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(CC(=O)OC)C2=C1CCNC2 DEHZQOLNSNVIHK-UHFFFAOYSA-N 0.000 description 1
- JZULUDYJULULLS-UHFFFAOYSA-N methyl 2-(bromomethyl)-3-fluorobenzoate Chemical compound COC(=O)C1=CC=CC(F)=C1CBr JZULUDYJULULLS-UHFFFAOYSA-N 0.000 description 1
- ZBNCXBRZFRYZMS-UHFFFAOYSA-N methyl 2-(cyanomethyl)-3-fluorobenzoate Chemical compound COC(=O)C1=CC=CC(F)=C1CC#N ZBNCXBRZFRYZMS-UHFFFAOYSA-N 0.000 description 1
- XTFUQNZBEFAKHW-UHFFFAOYSA-N methyl 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylate;hydrochloride Chemical compound Cl.C1NCCC2=C1C=C(C(=O)OC)S2 XTFUQNZBEFAKHW-UHFFFAOYSA-N 0.000 description 1
- RDBQMDQEQBBROF-UHFFFAOYSA-N methyl 5-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-6,7-dihydro-4h-thieno[3,2-c]pyridine-2-carboxylate Chemical compound C1CCC2=CC=CC(NC3=O)=C2C31CCCCN1CC(C=C(S2)C(=O)OC)=C2CC1 RDBQMDQEQBBROF-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- XIIQEOQKQGGTKI-UHFFFAOYSA-N n,n-diethyl-2-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-3,4-dihydro-1h-pyrido[3,4-b]indole-9-carboxamide Chemical compound C12=CC=CC=C2N(C(=O)N(CC)CC)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 XIIQEOQKQGGTKI-UHFFFAOYSA-N 0.000 description 1
- GLDFSSJVXDULKQ-UHFFFAOYSA-N n,n-dimethyl-1,2,3,4-tetrahydropyrido[3,4-b]indole-9-carboxamide;hydrochloride Chemical compound Cl.C12=CC=CC=C2N(C(=O)N(C)C)C2=C1CCNC2 GLDFSSJVXDULKQ-UHFFFAOYSA-N 0.000 description 1
- UALFGRGWDLRGSM-UHFFFAOYSA-N n,n-dimethyl-2-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)acetamide Chemical compound C12=CC=CC=C2N(CC(=O)N(C)C)C2=C1CCNC2 UALFGRGWDLRGSM-UHFFFAOYSA-N 0.000 description 1
- VKRIABWUQIFJPH-UHFFFAOYSA-N n,n-dimethyl-2-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C12=CC=CC=C2N(CC(=O)N(C)C)C2=C1CCNC2 VKRIABWUQIFJPH-UHFFFAOYSA-N 0.000 description 1
- BNLDNEGQLKGZII-UHFFFAOYSA-N n,n-dimethyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxamide Chemical compound C1NCCC2=C1C=C(C(=O)N(C)C)S2 BNLDNEGQLKGZII-UHFFFAOYSA-N 0.000 description 1
- YDDVFDYCEFZGMB-UHFFFAOYSA-N n-(3,4-dihydro-2h-1,4-benzothiazin-3-ylmethyl)-4-hydroxybutanamide Chemical compound C1=CC=C2NC(CNC(=O)CCCO)CSC2=C1 YDDVFDYCEFZGMB-UHFFFAOYSA-N 0.000 description 1
- HYVHSMSLCFIRFA-UHFFFAOYSA-N n-(furan-3-ylmethyl)-1-phenylmethanamine Chemical compound C1=COC=C1CNCC1=CC=CC=C1 HYVHSMSLCFIRFA-UHFFFAOYSA-N 0.000 description 1
- METAARIXCOAZDH-UHFFFAOYSA-N n-cyclohexyl-1-(4-methylphenyl)methanimine Chemical compound C1=CC(C)=CC=C1C=NC1CCCCC1 METAARIXCOAZDH-UHFFFAOYSA-N 0.000 description 1
- ANWSCQFYUDOLCH-UHFFFAOYSA-N n-fluoro-4-methyl-n-propylbenzenesulfonamide Chemical class CCCN(F)S(=O)(=O)C1=CC=C(C)C=C1 ANWSCQFYUDOLCH-UHFFFAOYSA-N 0.000 description 1
- CJYQZTZSYREQBD-UHFFFAOYSA-N n-fluorobenzenesulfonamide Chemical compound FNS(=O)(=O)C1=CC=CC=C1 CJYQZTZSYREQBD-UHFFFAOYSA-N 0.000 description 1
- RUMHTMNQOVBBRY-UHFFFAOYSA-N n-methyl-2-(1,2,3,4-tetrahydropyrido[3,4-b]indol-9-yl)acetamide Chemical compound C12=CC=CC=C2N(CC(=O)NC)C2=C1CCNC2 RUMHTMNQOVBBRY-UHFFFAOYSA-N 0.000 description 1
- WLEXIGGRHOXDNF-UHFFFAOYSA-N n-methyl-2-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-3,4-dihydro-1h-pyrido[3,4-b]indole-9-carboxamide Chemical compound C12=CC=CC=C2N(C(=O)NC)C2=C1CCN(CCCCC13C(NC=4C=CC=C(C3=4)CCC1)=O)C2 WLEXIGGRHOXDNF-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- XXMUVWBKJNJFOF-UHFFFAOYSA-N tert-butyl 3,4-dihydro-1h-[1]benzothiolo[2,3-c]pyridine-2-carboxylate Chemical compound S1C2=CC=CC=C2C2=C1CN(C(=O)OC(C)(C)C)CC2 XXMUVWBKJNJFOF-UHFFFAOYSA-N 0.000 description 1
- YUSMZDVTEOAHDL-UHFFFAOYSA-N tert-butyl 3-(dimethylaminomethylidene)-4-oxopiperidine-1-carboxylate Chemical compound CN(C)C=C1CN(C(=O)OC(C)(C)C)CCC1=O YUSMZDVTEOAHDL-UHFFFAOYSA-N 0.000 description 1
- YALDBRAWOJVXRF-UHFFFAOYSA-N tert-butyl 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine-1-carboxylate Chemical compound C1NCCC2=C1C=NN2C(=O)OC(C)(C)C YALDBRAWOJVXRF-UHFFFAOYSA-N 0.000 description 1
- MPRVNFLYIVNNAN-UHFFFAOYSA-N tert-butyl 4-(3,4-dihydro-2h-chromen-2-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1OC2=CC=CC=C2CC1 MPRVNFLYIVNNAN-UHFFFAOYSA-N 0.000 description 1
- UBYLDYRKWSCXAQ-UHFFFAOYSA-N tert-butyl 4-(3,4-dihydro-2h-chromen-4-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1C2=CC=CC=C2OCC1 UBYLDYRKWSCXAQ-UHFFFAOYSA-N 0.000 description 1
- WAHYOSBZOHZMHV-UHFFFAOYSA-N tert-butyl 4-(3,4-dihydro-2h-thiochromen-2-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1SC2=CC=CC=C2CC1 WAHYOSBZOHZMHV-UHFFFAOYSA-N 0.000 description 1
- JGSGDDQOULGAKS-UHFFFAOYSA-N tert-butyl 4-(3,4-dihydro-2h-thiochromen-4-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1C2=CC=CC=C2SCC1 JGSGDDQOULGAKS-UHFFFAOYSA-N 0.000 description 1
- ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 description 1
- CRSHBCSIJWVDOT-UHFFFAOYSA-N tert-butyl 6,7-dimethoxy-1-methyl-3,4-dihydro-1h-isoquinoline-2-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)C(C)C2=C1C=C(OC)C(OC)=C2 CRSHBCSIJWVDOT-UHFFFAOYSA-N 0.000 description 1
- HGSARGFDCSXUBC-UHFFFAOYSA-N tert-butyl 9-(cyanomethyl)-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound N#CCN1C2=CC=CC=C2C2=C1CN(C(=O)OC(C)(C)C)CC2 HGSARGFDCSXUBC-UHFFFAOYSA-N 0.000 description 1
- KMHNZGRISWSBEX-UHFFFAOYSA-N tert-butyl 9-[2-(methylamino)-2-oxoethyl]-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(CC(=O)NC)C2=C1CCN(C(=O)OC(C)(C)C)C2 KMHNZGRISWSBEX-UHFFFAOYSA-N 0.000 description 1
- CCHMUQRTLBOGLD-UHFFFAOYSA-N tert-butyl 9-propan-2-yl-3,4-dihydro-1h-pyrido[3,4-b]indole-2-carboxylate Chemical compound C12=CC=CC=C2N(C(C)C)C2=C1CCN(C(=O)OC(C)(C)C)C2 CCHMUQRTLBOGLD-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 1
- YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
- C07D209/92—Naphthostyrils
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35838197A JPH11189585A (ja) | 1997-12-25 | 1997-12-25 | 5−ht7受容体結合能を有するテトラヒドロベンズインドール誘導体 |
JP35838097 | 1997-12-25 | ||
JP8591398 | 1998-03-31 | ||
JP13687298 | 1998-05-19 | ||
JP22970998 | 1998-08-14 | ||
JP31933698 | 1998-11-10 | ||
PCT/JP1998/005827 WO1999033804A1 (fr) | 1997-12-25 | 1998-12-22 | Derives de tetrahydrobenzindole |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20003285D0 NO20003285D0 (no) | 2000-06-22 |
NO20003285L NO20003285L (no) | 2000-08-23 |
NO317293B1 true NO317293B1 (no) | 2004-10-04 |
Family
ID=27551662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003285A NO317293B1 (no) | 1997-12-25 | 2000-06-22 | Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse |
Country Status (12)
Country | Link |
---|---|
US (1) | US6498251B1 (zh) |
EP (1) | EP1057814B1 (zh) |
JP (1) | JP4459437B2 (zh) |
KR (1) | KR100588249B1 (zh) |
CN (1) | CN1129578C (zh) |
AT (1) | ATE290527T1 (zh) |
CA (1) | CA2316388C (zh) |
DE (1) | DE69829317T2 (zh) |
DK (1) | DK1057814T3 (zh) |
ES (1) | ES2238778T3 (zh) |
NO (1) | NO317293B1 (zh) |
WO (1) | WO1999033804A1 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407112B1 (en) * | 1998-04-22 | 2002-06-18 | Meiji Seika Kaisha, Ltd. | Optically active tetrahydrobenzindole derivative |
UA69420C2 (uk) * | 1998-10-06 | 2004-09-15 | Янссен Фармацевтика Н.В. | ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ |
GB9828004D0 (en) * | 1998-12-18 | 1999-02-10 | Smithkline Beecham Plc | Use |
AU1025601A (en) * | 1999-10-18 | 2001-04-30 | Smithkline Beecham Plc | Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists |
AR035417A1 (es) * | 2001-01-27 | 2004-05-26 | Hoffmann La Roche | Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos |
WO2004018432A1 (en) * | 2002-08-20 | 2004-03-04 | Eli Lilly And Company | Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
WO2005012310A1 (ja) * | 2003-08-04 | 2005-02-10 | Soda Aromatic Co.,Ltd. | チエノピリジン系化合物の香料における使用、および新規チエノピリジン系化合物 |
NZ551543A (en) * | 2004-05-11 | 2009-12-24 | Egis Gyogyszergyar Nyrt | Pyridine derivatives of alkyl oxindoles as 5-HT7 receptor active agents |
DE602006012650D1 (de) * | 2005-04-26 | 2010-04-15 | Hypnion Inc | Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung |
EP2054416B8 (en) * | 2006-08-04 | 2014-07-16 | Merz Pharma GmbH & Co. KGaA | Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
EP1956006A1 (en) | 2007-02-06 | 2008-08-13 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted-tetrahydro-naphthalen derivatives as 5-HT7 receptor ligands |
EP1975161A1 (en) * | 2007-03-28 | 2008-10-01 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments |
US8338447B2 (en) | 2008-03-24 | 2012-12-25 | Medivation Technologies, Inc. | Pyrido[3,4-B]indoles and methods of use |
EP2480079A4 (en) * | 2009-09-23 | 2015-04-08 | Medivation Technologies Inc | PYRIDO- (3,4-B-) INDOLE AND USE METHOD THEREFOR |
CN108623585B (zh) * | 2018-05-22 | 2021-07-09 | 中国人民解放军第二军医大学 | β-四氢咔啉类抗真菌药物及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69733427T2 (de) | 1996-06-28 | 2006-04-27 | Meiji Seika Kaisha Ltd. | Tetrahydrobezindol derivate |
US6407112B1 (en) | 1998-04-22 | 2002-06-18 | Meiji Seika Kaisha, Ltd. | Optically active tetrahydrobenzindole derivative |
-
1998
- 1998-12-22 US US09/582,416 patent/US6498251B1/en not_active Expired - Fee Related
- 1998-12-22 EP EP98961493A patent/EP1057814B1/en not_active Expired - Lifetime
- 1998-12-22 KR KR1020007007122A patent/KR100588249B1/ko not_active IP Right Cessation
- 1998-12-22 CA CA002316388A patent/CA2316388C/en not_active Expired - Fee Related
- 1998-12-22 DE DE69829317T patent/DE69829317T2/de not_active Expired - Lifetime
- 1998-12-22 CN CN98813811A patent/CN1129578C/zh not_active Expired - Fee Related
- 1998-12-22 JP JP2000526488A patent/JP4459437B2/ja not_active Expired - Fee Related
- 1998-12-22 DK DK98961493T patent/DK1057814T3/da active
- 1998-12-22 WO PCT/JP1998/005827 patent/WO1999033804A1/ja active IP Right Grant
- 1998-12-22 ES ES98961493T patent/ES2238778T3/es not_active Expired - Lifetime
- 1998-12-22 AT AT98961493T patent/ATE290527T1/de not_active IP Right Cessation
-
2000
- 2000-06-22 NO NO20003285A patent/NO317293B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100588249B1 (ko) | 2006-06-13 |
ES2238778T3 (es) | 2005-09-01 |
WO1999033804A1 (fr) | 1999-07-08 |
DE69829317D1 (de) | 2005-04-14 |
EP1057814B1 (en) | 2005-03-09 |
NO20003285D0 (no) | 2000-06-22 |
CN1286683A (zh) | 2001-03-07 |
US6498251B1 (en) | 2002-12-24 |
DE69829317T2 (de) | 2006-04-06 |
CA2316388A1 (en) | 1999-07-08 |
JP4459437B2 (ja) | 2010-04-28 |
KR20010033609A (ko) | 2001-04-25 |
NO20003285L (no) | 2000-08-23 |
DK1057814T3 (da) | 2005-07-04 |
EP1057814A1 (en) | 2000-12-06 |
ATE290527T1 (de) | 2005-03-15 |
CA2316388C (en) | 2009-09-08 |
EP1057814A4 (en) | 2001-07-11 |
CN1129578C (zh) | 2003-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2615403C (en) | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | |
NO317293B1 (no) | Tetrahydrobenzindolderivat, farmasoytisk preparat samt mellomproduktforbindelse | |
JP3531169B2 (ja) | 縮合ヘテロ環化合物およびその医薬用途 | |
US20040138230A1 (en) | Heterocyclic substituted piperazines for the treatment of schizophrenia | |
US20100152177A1 (en) | Compounds having 5-ht6 receptor affinity | |
TWI483946B (zh) | 5-ht受體調節劑及其使用方法 | |
KR20090114439A (ko) | 아실구아니딘 유도체 | |
US20080200471A1 (en) | 6' substituted compounds having 5-ht6 receptor affinity | |
US20080318941A1 (en) | 4' substituted compounds having 5-ht6 receptor affinity | |
JP2007517014A (ja) | N−置換ピペリジン及びピペラジン誘導体 | |
NO129043B (zh) | ||
SK285594B6 (sk) | Gama-karbolín, spôsob jeho prípravy a kompozícia s jeho obsahom | |
CA2797019C (en) | Modulators of 5-ht receptors and methods of use thereof | |
NO311515B1 (no) | Tetrahydrobenzindolforbindelser, og farmasöytiske preparater inneholdende slike forbindelser | |
CA2617473A1 (en) | Acylguanidine derivative or salt thereof | |
US6407112B1 (en) | Optically active tetrahydrobenzindole derivative | |
WO1996024594A1 (fr) | Derives de benzodiazepines, sels issus de ces derives, et medicaments a base de ces derives et sels | |
KR100539724B1 (ko) | 항정신병성약제로서의헥사하이드로-피리도(4,3-b)인돌유도체 | |
AU2012202570B2 (en) | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | |
JP2021119130A (ja) | 縮環ラクタム誘導体からなる医薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ERR | Erratum |
Free format text: TETRAHYDROBENZINDOLDERIVAT, FARMASOYTISK PREPARAT SAMT MELLOMPRODUKTFORBINDELSE |
|
MM1K | Lapsed by not paying the annual fees |